Holen Sie sich die Stockscreener-App
10.36
4.95%
-0.54
Handel nachbörslich:
10.20
-0.16
-1.54%
Schlusskurs vom Vortag:
$10.90
Offen:
$10.95
24-Stunden-Volumen:
1.22M
Relative Volume:
1.59
Marktkapitalisierung:
$1.26B
Einnahmen:
$58.49M
Nettoeinkommen (Verlust:
$-105.04M
KGV:
-7.9711
EPS:
-1.2997
Netto-Cashflow:
$-13.78M
1W Leistung:
+10.21%
1M Leistung:
+78.31%
6M Leistung:
+160.96%
1J Leistung:
+10.86%
1-Tages-Spanne:
$10.20
$10.95
1-Wochen-Bereich:
$9.0975
$10.95
52-Wochen-Spanne:
$3.30
$10.95
Immatics N V Stock (IMTX) Company Profile
Vergleichen Sie IMTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.36 | 1.32B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-18 | Eingeleitet | Guggenheim | Buy |
| 2025-05-28 | Eingeleitet | Deutsche Bank | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-31 | Eingeleitet | Mizuho | Buy |
| 2023-03-24 | Eingeleitet | Bryan Garnier | Buy |
| 2020-11-20 | Eingeleitet | BofA Securities | Buy |
| 2020-09-22 | Eingeleitet | Goldman | Buy |
| 2020-07-27 | Eingeleitet | SVB Leerink | Outperform |
| 2020-07-24 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Immatics N V Aktie (IMTX) Neueste Nachrichten
Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 (NASDAQ:IMTX) - Seeking Alpha
What institutional flow reveals about Immatics N.V.Market Performance Recap & Real-Time Volume Surge Alerts - newser.com
Will Immatics N.V. rebound enough to break evenEntry Point & Real-Time Buy Signal Alerts - newser.com
Why Immatics N.V. (4A3) stock is a must watch tickerEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
How sentiment analysis helps forecast Immatics N.V. Equity WarrantEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Immatics NV Stock Analysis and ForecastMarket Volatility Update & You’ll Thank Yourself in 6 Months - earlytimes.in
Immatics N.V. stock trend forecast2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Analyzing Immatics N.V. with risk reward ratio charts2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
Can technical indicators confirm Immatics N.V.’s reversalMarket Volume Report & Stock Timing and Entry Methods - newser.com
Immatics' (IMTX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Reversal indicators forming on Immatics N.V. Equity Warrant stockDollar Strength & Real-Time Volume Surge Alerts - newser.com
How supply shortages influence Immatics N.V. (4A3) stock2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Using Bollinger Bands to evaluate Immatics N.V. Equity WarrantOptions Play & Step-by-Step Trade Execution Guides - newser.com
Is Immatics N.V. stock a dividend growth opportunityLong Setup & Reliable Breakout Stock Forecasts - newser.com
Using R and stats models for Immatics N.V. forecastingOil Prices & Free Technical Pattern Based Buy Signals - newser.com
Is Immatics N.V. stock ready for a breakoutBuy Signal & Technical Pattern Based Signals - newser.com
Is Immatics N.V. (4A3) stock vulnerable to rate hikesMarket Weekly Review & Weekly Momentum Picks - newser.com
Will Immatics N.V. Equity Warrant rebound enough to break evenTrend Reversal & Consistent Growth Stock Picks - newser.com
Custom watchlist performance reports with Immatics N.V.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-05 03:07:55 - newser.com
Will Immatics (IMTX) Gain Momentum as New CFO Brings Biopharma Commercialization Expertise? - simplywall.st
Earnings visualization tools for Immatics N.V.Weekly Trade Analysis & Daily Oversold Stock Bounce Ideas - newser.com
Historical volatility pattern of Immatics N.V. visualizedMarket Performance Recap & Low Drawdown Investment Ideas - newser.com
Published on: 2025-10-03 05:43:05 - newser.com
Candlestick signals on Immatics N.V. Equity Warrant stock todayJuly 2025 Drop Watch & High Return Trade Opportunity Guides - newser.com
Published on: 2025-10-03 03:04:39 - newser.com
What analyst consensus says on Immatics N.V. Equity Warrant stockStop Loss & High Accuracy Swing Entry Alerts - newser.com
Reversal indicators forming on Immatics N.V. stockIPO Watch & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-10-02 21:13:24 - newser.com
Immatics Appoints New CFO to Drive PRAME Therapy Commercialization - The Globe and Mail
Former bluebird CEO picked to lead Inventiva - BioCentury
Immatics appoints industry veteran as CFO - MSN
Immatics Appoints Venkat Ramanan as Chief Financial Officer - GlobeNewswire
Can Immatics N.V. rally from current levelsVolume Spike & Safe Capital Growth Tips - newser.com
Finanzdaten der Immatics N V-Aktie (IMTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):